Immunotech Laboratories, Inc.

IMMB · OTC
Analyze with AI
12/31/2016
9/30/2016
6/30/2016
9/30/2006
Assets
Cash & Equivalents$14$0$0$19
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$128
Other Curr. Assets$0$0$0$0
Total Curr. Assets$14$0$0$147
Property Plant & Equip (Net)$305$309$313$3
Goodwill$0$0$0$0
Intangibles$0$0$0$230
Long-Term Investments$200$200$200$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$3
Total NC Assets$10,519$10,523$10,527$236
Other Assets$0$0$0$0
Total Assets$10,533$10,523$10,527$383
Liabilities
Payables$0$0$0$297
Short-Term Debt$773$759$759$484
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,316$3,200$3,085$1,690
Total Curr. Liab.$4,089$3,959$3,844$2,470
LT Debt$1,646$1,646$1,646$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,646$1,646$1,646$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,734$5,605$5,489$2,470
Equity
Pref Stock$260$260$260$4
Common Stock$575$575$575$26
Retained Earnings-$4,000-$3,881-$3,761-$76,545
AOCI$0$0$0$0
Other Equity$8,539$8,539$8,539$74,427
Total Equity$4,799$4,918$5,038-$2,088
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,533$10,523$10,527$383
Net Debt$2,404$2,404$2,404$465